(NIH) - A first-in-human clinical trial of an experimental oral drug for removing radioactive contaminants from inside the body has begun. The trial is testing the safety, tolerability and processing in the body of escalating doses of the investigational drug product HOPO 14-1 in healthy adults. The National Institute of Allergy and Infectious Diseases (NIAID), […]
The post First-in-human trial of oral drug to remove radioactive contamination begins appeared first on North Dallas Gazette.
